Evidence map›Paper›PMID 36349243›Full record

ArticleJAC-antimicrobial resistance2022

Occurrence and significance of fluoroquinolone-resistant and ESBL-producing

Appiah-Korang Labi, Noah Obeng-Nkrumah, Nicholas T K D Dayie, Ben Molai Addo, Mary-Magdalene Osei, Ama Fenny, Beverly Egyir, James Edward Mensah

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Microbiology spectrum · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Appiah-Korang LabiDepartment of Microbiology, Korle-Bu Teaching Hospital, PO Box 77, Accra, Ghana.ORCID https://orcid.org/0000-0001-7276-7057
Noah Obeng-NkrumahDepartment of Medical Laboratory Sciences, University of Ghana School of Biomedical and Allied Health Sciences, PO Box KB 143, Accra, Ghana.ORCID https://orcid.org/0000-0002-1797-822X
Nicholas T K D DayieDepartment of Medical Microbiology, University of Ghana Medical School, PO Box KB 143, Accra, Ghana.ORCID https://orcid.org/0000-0003-4491-6902
Ben Molai AddoDepartment of Surgery, Urology Clinic, Korle-Bu Teaching Hospital, PO Box 77, Accra, Ghana.
Mary-Magdalene OseiDepartment of Medical Microbiology, University of Ghana Medical School, PO Box KB 143, Accra, Ghana.
Ama FennyInstitute of Statistical, Social and Economic Research, University of Ghana, PO Box LG74, Accra, Ghana.
Beverly EgyirDepartment of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, P. O. Box LG 581, Accra, Ghana.
James Edward MensahDepartment of Surgery University of Ghana Medical School, PO Box 4236, Accra, Ghana.ORCID https://orcid.org/0000-0003-4133-1722
University of Ghana · GHKorle Bu Teaching Hospital · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Reports suggest that fluoroquinolone (FQ)-resistant and ESBL-producing rectal flora are associated with infectious complications in men undergoing transrectal ultrasound-guided prostate needle biopsy (TRUS-B). Objectives: We investigated the relationship between carriage of FQ-resistant and ESBL-producing Methods: From 1 January 2018 to 30 April 2019, rectal swabs of 361 patients were cultured pre-TRUS-B for FQ-resistant and ESBL-producing flora. Patients were followed up for 30 days for infectious complications post-biopsy. Multivariable logistic regression analyses were used to identify risk factors. Results: Overall, 86.4% ( Conclusions: The findings suggest that a change in prophylactic antibiotics to a more targeted regimen may be warranted in our institution.

Identifiers

PMID36349243
PMCPMC9636584
OpenAlexW4308307566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.